178 related articles for article (PubMed ID: 26863637)
41. ATF5 increases cisplatin-induced apoptosis through up-regulation of cyclin D3 transcription in HeLa cells.
Wei Y; Jiang J; Sun M; Chen X; Wang H; Gu J
Biochem Biophys Res Commun; 2006 Jan; 339(2):591-6. PubMed ID: 16300731
[TBL] [Abstract][Full Text] [Related]
42. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
[TBL] [Abstract][Full Text] [Related]
43. ATF5 is a highly abundant liver-enriched transcription factor that cooperates with constitutive androstane receptor in the transactivation of CYP2B6: implications in hepatic stress responses.
Pascual M; Gómez-Lechón MJ; Castell JV; Jover R
Drug Metab Dispos; 2008 Jun; 36(6):1063-72. PubMed ID: 18332083
[TBL] [Abstract][Full Text] [Related]
44. Preferential replication of systemically delivered oncolytic vaccinia virus in focally irradiated glioma xenografts.
Advani SJ; Buckel L; Chen NG; Scanderbeg DJ; Geissinger U; Zhang Q; Yu YA; Aguilar RJ; Mundt AJ; Szalay AA
Clin Cancer Res; 2012 May; 18(9):2579-90. PubMed ID: 22379115
[TBL] [Abstract][Full Text] [Related]
45. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
[TBL] [Abstract][Full Text] [Related]
46. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
[TBL] [Abstract][Full Text] [Related]
47. The anti-angiogenic role of soluble-form VEGF receptor in malignant gliomas.
Takano S; Ishikawa E; Matsuda M; Sakamoto N; Akutsu H; Yamamoto T; Matsumura A
Int J Oncol; 2017 Feb; 50(2):515-524. PubMed ID: 28000842
[TBL] [Abstract][Full Text] [Related]
48. Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells.
Ishihara S; Yasuda M; Ishizu A; Ishikawa M; Shirato H; Haga H
Oncotarget; 2015 Mar; 6(7):4602-14. PubMed ID: 25682872
[TBL] [Abstract][Full Text] [Related]
49. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.
Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA
Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515
[TBL] [Abstract][Full Text] [Related]
50. Human Cytomegalovirus Infection Activates Glioma Activating Transcription Factor 5 via microRNA in a Stress-Induced Manner.
Hu M; Yu B; Zhang B; Wang B; Qian D; Li H; Ma J; Liu DX
ACS Chem Neurosci; 2021 Oct; 12(20):3947-3956. PubMed ID: 34617722
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells.
Ohba S; Hirose Y; Yoshida K; Yazaki T; Kawase T
J Neurosurg; 2010 Jan; 112(1):33-42. PubMed ID: 19408974
[TBL] [Abstract][Full Text] [Related]
52. RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis.
Wang Q; Wang JY; Zhang XP; Lv ZW; Fu D; Lu YC; Hu GH; Luo C; Chen JX
Carcinogenesis; 2013 Apr; 34(4):916-26. PubMed ID: 23276796
[TBL] [Abstract][Full Text] [Related]
53. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
54. Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers.
Greene LA; Zhou Q; Siegelin MD; Angelastro JM
Cells; 2023 Feb; 12(4):. PubMed ID: 36831248
[TBL] [Abstract][Full Text] [Related]
55. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
[TBL] [Abstract][Full Text] [Related]
56. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
57. The HIV-derived protein Vpr52-96 has anti-glioma activity in vitro and in vivo.
Kübler J; Kirschner S; Hartmann L; Welzel G; Engelhardt M; Herskind C; Veldwijk MR; Schultz C; Felix M; Glatting G; Maier P; Wenz F; Brockmann MA; Giordano FA
Oncotarget; 2016 Jul; 7(29):45500-45512. PubMed ID: 27275537
[TBL] [Abstract][Full Text] [Related]
58. Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.
Lo HW; Cao X; Zhu H; Ali-Osman F
Clin Cancer Res; 2008 Oct; 14(19):6042-54. PubMed ID: 18829483
[TBL] [Abstract][Full Text] [Related]
59. A peptide derived from apoptin inhibits glioma growth.
Zhang L; Zhao H; Cui Z; Lv Y; Zhang W; Ma X; Zhang J; Sun B; Zhou D; Yuan L
Oncotarget; 2017 May; 8(19):31119-31132. PubMed ID: 28415709
[TBL] [Abstract][Full Text] [Related]
60. miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells.
Li XT; Wang HZ; Wu ZW; Yang TQ; Zhao ZH; Chen GL; Xie XS; Li B; Wei YX; Huang YL; Zhou YX; Du ZW
Cell Mol Neurobiol; 2015 Jul; 35(5):679-87. PubMed ID: 25662849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
